Harmony Biosciences Holdings, Inc. (HRMY)
Market Closed
2 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
37. 26
+1.26
+3.5%
$
2.05B Market Cap
13.86 P/E Ratio
- Div Yield
1.01M Volume
3.01 Eps
$ 36
Previous Close 
Want to track HRMY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Harmony Biosciences Holdings, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 William Staveacre Aster Capital Management (DIFC) Ltd. | 105 | $2,941.05 | $3,912.3 | $971.25 | 33.02% |
 Bayforest Capital Ltd. Bayforest Capital Ltd. | 5,829 | $163,270 | $217,188.54 | $53,918.54 | 33.02% |
 SummitTX Capital LP SummitTX Capital LP | 10,694 | $299,539 | $398,458.44 | $98,919.44 | 33.02% |
| AH Amanda Holloway Illumine Investment Management LLC | 24,277 | $764,615.67 | $904,561.02 | $139,945.35 | 18.3% |
| BM Berkeley Meredith Hughes Financial Services LLC | 1 | $28 | $37.26 | $9.26 | 33.07% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 23,548 | $654,883.91 | $877,398.48 | $222,514.57 | 33.98% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 1,294 | $43,163.51 | $48,214.44 | $5,050.93 | 11.7% |
| JCB John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH | 259,187 | $8.19M | $9.66M | $1.46M | 17.85% |
